OneProjects operates at the intersection of hardware, software and data science to create the future vision for healthcare and how we successfully treat patients in a new era for data driven solutions.
OneProjects are developing VERAFEYE, a connected platform technology to revolutionise the treatment of AFib and cardiac arrhythmias. By moving the treatment strategy from experience-based to evidence-based success, the VERAFEYE system will improve outcomes for patients, increase procedural safety and reduce cost to the healthcare system.
OneProjects is a privately held, venture backed medical device company based in Dublin (Ireland) and Munich (Germany) originating from Bioinnovate Ireland and spun out of Trinity College Dublin. OneProjects was by founded by Fionn Lahart and Christoph Hennersperger in 2017.
- Invested amount
EUR 1 068 830